AR and cancer: In muscle-invasive tumors, p-ELK1 positivity strongly correlated with cancer-specific survival (HR = 2.693, P = 0.021), whereas positivity of AR (HR = 2.280, P = 0.042), but not that of p-ELK1, was identified as a strong predictor for disease progression.